An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer

星级：  9 页

Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer

星级：  8 页

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy

星级：  7 页

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer A Systemati

星级：  5 页

Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer

星级：  12 页

Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells

星级：  15 页

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer

星级：  6 页

Androgen Deprivation Therapy for Treatment of Localized Prostate Cancer and Risk of Second Primary Malignancies

星级：  1 页

Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer

星级：  7 页